Crimean-Congo haemorrhagic fever: an overview

Virat J. Agravat, Sneha Agarwal, Kiran G. Piparva


Crimean-Congo Hemorrhagic Fever (CCHF) is an acute, highly-contagious and life-threatening vector borne disease. The CCHF virus causes severe viral hemorrhagic fever outbreaks, with a case fatality rate of 10-40%. CCHF virus isolation and/or disease has been reported from more than 30 countries in Africa, Asia, South eastern Europe and Middle east. Jan 2011 marks first ever reports of outbreak of CCHF in India, total 5 cases were detected of CCHF from Gujarat. CCHF has recently in news again, 6 human cases and 32 animal samples test positive for CCHF from Kariyana village of Amreli district (Gujarat state) July 2013. Crimean-Congo hemorrhagic fever virus (CCHFV), member of genus Nairovirus in the family Bunyaviridae. Numerous genera of ixodid ticks serve both as vector and reservoir for CCHFV. Human infections occurred through tick bites, direct contact with blood or tissue of infected livestock, or nosocomial infections. Human infections begin with nonspecific febrile symptoms, but progress to a serious hemorrhagic syndrome with a high case fatality ratio. The most definitive way of diagnosis is the demonstration of virus or viral genome in sera samples. Hospitalization in special care unit with constant effort to prevent haemorrhagic complication along with laboratory monitoring is cornerstone for treatment of CCHF. Till date there is no FDA approved drug or definitive treatment for CCHF, ribavirin is tried by many physician need to be evaluated further. Current article is an effort to update existing knowledge about CCHF by due focus on various aspects especially prevention of this zoonotic disease. Much of the real life queries about this disease are elaborated after extensive literature research.



CCHF, Zoonotic disease, Hemorrhagic fever, Ribavirin

Full Text:



Maltezou HC, Papa A.CCHF: Epidemiology trends and controversies on treatment. BMC Med. 2011;9:131:1-5.

Epidemic Investigation Cell Public Health Laboratories Division National Institute of Health, Islamabad. Guidelines for Crimean-Congo Haemorrhagic Fever (CCHF), 2008. Available at: Accessed January 2008.

WHO. Crimean-Congo haemorrhagic fever, 2013. Available at: Accessed January 2013.

Appannanavar SB, Mishra B. An update on Crimean Congo haemorrhagic fever. J Glob Infect Dis. 2011 Jul-Sep;3(3):285-92.

Yilmaz GR, Buzgan T, Torunglu MA, Safran A, Irmak H, Com S et al. A preliminary report on CCHF in Turkey, March-June 2008. Ecosurveillance. 2008 July-Sep;13(7-9):1.

Yadav PD, Raut CG, Patil DY, Majumdar TD, Mourya DT. Crimean-Congo haemorrhagic fever: current scenario in India. Proceedings of the National Academy of Sciences, India. Biol Sci. 2014;84:9-18.

Dikid T, Jain SK, Sharma A, Kumar A, Narain JP. Emerging & re-emerging infections in India: an overview. Indian J Med Res. 2013 July;138:19-31.

Maurya TD, Yadav PD, Shete AM, Gaurav YK, Rawt CG, Jadi RS et al. Diagnosis, isolation and confirmation of CCHF in humans, Ticks and Animals in Ahmadabad, India, 2010-2011. PLos Neglect Trop Dis. 2012 May;6(5):1653.

Mourya DT. 6 from Guj test positive for Congo fever: NIV Times, 2013. Available at:

Indian Express. Congo fever kills 2 in Amreli village, 2013. Available at:

Tropical Medical Bureau. 6 cases of Crimean-Congo haemorrhagic fever in Gujarat state of India, 2013. Available at:

European centre for Disease, Prevention and Control. Consultation on CCHF prevention and control, 2008. Accessed 15 November 2011.

Whitehouse CA. Crimean Congo haemorrhagic fever. Antiviral Res. 2004;64:145-60.

Fabentech. Crimean-Congo hemorrhagic fever virus, 2011. Available at:

Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. CCHFV genomics and global diversity. J Virol. 2006 Sept;80(17):8834-42.

Izadi S, Naieni KH, Majdzadeh SR, Chinikar S, Nadim A, Rakhshar F et al. Seroprevelance of CCHF in Seston-va-Baluchestan Province of iran. Japan J Infect Dis. 2006;59:326-8.

Palomar AM, Portillo A, Santibanez P, Mazuelas D, Arizaga J, Crespo A et al. Crimean Congo haemorrhagic fever virus in tick from migratory birds, Morocco. Emerg Infect Dis. 2013 Feb;19(2):260-3.

Gear JHS. What is Congo-Crimean Haemorrhagic Fever? South Africa Med J. 1982 Oct;62:576-80.

Bajpai S, Nadkar MY. CCHF: requires vigilance and not panic. J Assoc Physicians India. 2011 Mar;59:164-6.

Naderi HR, Sheybani F, Bojdi A, Khosravi N, Mostafavi I. Fatal nosocomial spread of Crimean-Congo haemorrhagic fever with very short incubation period. Am J Trop Med Hyg. 2013 Mar;88(3):469-71.

Zavitsanou A, Babatsikou, Koutis C. CCHF: an emerging tick-borne disease. Health Sci J. 2009;3(1):10-5.

Centers for Disease Control and Prevention (CDC). Crimean Congo haemorrhagic fever, 2012. Available at:

Saijo M, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D et al. Possible horizontal transmission of CCHFV from mother to her child. Japan J Infect Dis 2004;57:55-7.

Kara M. Global warming and parasites. Kafkas Univ Vet Fak Derg. 2012;18(A):245-8.

Center for Food Security and Public Health. Crimean Congo hemorrhagic fever, 2007. Available at:

Centers for Disease Control and Prevention (CDC). Crimean Congo haemorrhagic fever, 2012. Available at:

Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo haemorrhagic fever in a recent outbreak in turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-7.

Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infect. 1997;25:364-7.

Mardani M, Pourkaveh B. Crimean Congo haemorrhagic fever. Iran J Clin Infect Dis. 2012;7(1):35-40.

Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R et al. Crimean-Congo haemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-84.

Public Health Agency Canada Crimean Congo haemorrhagic fever, 2001. Available at:

Patel AK, Patel KK, Mehta M, Parikh TM, Toshniwal H, Patel K. First Crimean Congo haemorrhagic fever outbreak in India. J Assoc Physicians India. 2011 Sept;5:585-89.

Science Daily. Tick by tick: Studying Crimean-Congo haemorrhagic fever virus carried by ticks, 2013. Available at:

Director General of Health Services Ministry of Health and Family Welfare. Treatment protocol for Crimean Congo haemorrhagic fever, 2010. Available at:

Centers for Disease Control and Prevention (CDC). Crimean Congo haemorrhagic fever, 2012. Available at:

Rusnak JM. Experience with ribavirin for treatment and post-exposure prophylaxis of haemorrhagic fever viruses: Crimean Congo haemorrhagic fever virus, hanta virus and lassa virus. Appl Biosaf. 2011;16(2):67-81.

Clingiroglu N, Tenal F, Altintas H. Public’s knowledge, opinions and behaviours about Crimean Congo haemorrhagic fever: an example from turkey. Kafkas Univ Vet Fak Derg. 2010;16(A):S17-22.

Centers for Disease Control and Prevention (CDC). Crimean Congo haemorrhagic fever, 2012. Available at:

Illustrated Lecture Notes on Tropical Medicine. Crimean Congo haemorrhagic fever, 2013. Available at:

Medindia. Crimean Congo haemorrhagic fever, 2013. Available at:

Dunster L, Dunster M, Ofula V, Beti D, Vokampf KF, Burt F et al. First Documentation of Human Crimean Congo haemorrhagic fever, Kenya. Emerg Infect Dis. 2002 Sept;8(9):1005-6.

Gozel MG, Dokmetas I, Oztop AY, Engin A, Eladi N, Bakir M. Recommended precaution procedures from CCHFV. Int J Infect Dis. 2013 Nov;17(11):e1046-50.

Centers for Disease Control and Prevention (CDC). Management of patients with suspected viral haemorrhagic fever, 2012. Available at:

Advisory Committee on Dangerous Pathogens. Management of hazardous group 4 viral haemorrhagic fevers and similar human infectious disease of high consequences, 2012. Available at: